Tue, Sep 2, 2014, 3:32 AM EDT - U.S. Markets open in 5 hrs 58 mins

Recent

% | $
Quotes you view appear here for quick access.

Brainstorm Cell Therapeutics Inc. Message Board

  • gizzy2020 gizzy2020 Aug 16, 2013 5:54 PM Flag

    read the quarterly

     

    since 2000, they have spent $45,000,000 of investment money without making a dime. They keep issuing shares to keep the cash cow coming in...they might make money in 2017... This has been going on with these stem companies for years... YOU pay their salaries

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • In 2008 this went from .64 cents to .07 cents. They are finally entering the point of which they can do some clinical trials. They have accomplished a lot, but as all these stem cell companies, it is at a Turtles pace.
      That is a heck of a lot of money and I only have been following bcli for about two years. CUR spends about $3 million per quarter (gosh hope I am recalling this correctly) and this company is basically their competition, but CUR is working on a lot more.
      With a market cap around $30 million; it is difficult to project appropriate value due to lack of ALS evidence with exception to the Miracle at Mayo. If in Phase I this is reaffirmed and these stem cells can be considered for other Dystrophy diseases and Parkinson's then the sky is the limit.
      There will definitely be a case of coverage once one of these regenerative stem cell companies are approved, but we'll cross that bridge at a later date.

 
BCLI.OB
0.00(0.00%)

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Exelixis, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Splunk, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT